THE REGULATION OF rDNA TECHNOLOGY DERIVED DRUGS: BIOTECH SPECIFIC ASPECTS
WHY SHOULD YOU ATTEND?- Gain a refresher/update on the technical aspects specific to the regulation of rDNA derived medicinal products
- Improve your knowledge of the differences between the regulation of rDNA products and conventional small molecule drugs
- Compare experiences with delegates from across Europe
WHO SHOULD ATTEND?
- Life scientists moving into biotech regulatory affairs
- Technical and scientific decision makers in biotech start up operations
- Those with a life science background in the financial sector involved in due diligence or regulatory portfolio
- Those from small molecule backgrounds transferring to biotech product regulatory affairs
Dates
Mar 11,2010 - Mar 11,2010 (Ended)
Venue
Address
11 Thurloe Place,
London,
United Kingdom
London,
United Kingdom
Prices *
545 Pound Sterling
Organization
Management Forum
Categories
Health: Pharma
Important
Due to possible changes in conference details, we recommend that you check with the conference website, before making any traveling arrangements.
Due to possible changes in conference details, we recommend that you check with the conference website, before making any traveling arrangements.
* Prices are for evaluation only. For accurate prices, please check with conference website.
from €108.03*
